Top compounds associated with response to SPRYD3


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA GSK-J4 CTRPv2 pan-cancer AAC -0.4 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA Merck60 CTRPv2 pan-cancer AAC -0.11 0.0003
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA Axitinib CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.2 0.0005
Download CSV